Cyclerion Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Cyclerion Therapeutics, Inc.‘s stocks are currently a part of 17 hedge funds’ portfolios, which represents 23.94% of the total amount of its stocks outstanding. This makes up a total of 10.40M shares of Cyclerion Therapeutics, Inc.. Compared to the previous quarter, the number fell by -50.03% or -10.41M shares fewer. As for the holding position changes, 52.94% (9) of current holders sold a part of the shares held, and 41.18% (7) closed the holdings completely. 2 hedge funds are new holders of Cyclerion Therapeutics, Inc. stock in Q1 2023, it is 11.76% of total holders.
Hedge funds holding Cyclerion Therapeutics (Q1 2019 – Q1 2023)
Q1 2019 | 3 |
---|---|
Q2 2019 | 96 |
Q3 2019 | 86 |
Q4 2019 | 70 |
Q1 2020 | 71 |
Q2 2020 | 69 |
Q3 2020 | 68 |
Q4 2020 | 69 |
Q1 2021 | 68 |
Q2 2021 | 61 |
Q3 2021 | 54 |
Q4 2021 | 48 |
Q1 2022 | 41 |
Q2 2022 | 33 |
Q3 2022 | 29 |
Q4 2022 | 37 |
Q1 2023 | 17 |
Hedge funds changes in Cyclerion Therapeutics positions (Q1 2019 – Q1 2023)
Q1 2019 | 3 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q2 2019 | 93 | 1 | 1 | 0 | 1 |
Q3 2019 | 7 | 36 | 17 | 16 | 10 |
Q4 2019 | 15 | 22 | 17 | 26 | -10 |
Q1 2020 | 18 | 17 | 21 | 17 | -2 |
Q2 2020 | 11 | 18 | 24 | 13 | 3 |
Q3 2020 | 10 | 19 | 24 | 11 | 4 |
Q4 2020 | 14 | 22 | 19 | 12 | 2 |
Q1 2021 | 7 | 27 | 16 | 8 | 10 |
Q2 2021 | 13 | 15 | 20 | 20 | -7 |
Q3 2021 | 8 | 13 | 22 | 13 | -2 |
Q4 2021 | 10 | 11 | 14 | 16 | -3 |
Q1 2022 | 3 | 10 | 16 | 10 | 2 |
Q2 2022 | 5 | 6 | 10 | 12 | 0 |
Q3 2022 | 1 | 4 | 12 | 6 | 6 |
Q4 2022 | 13 | 7 | 7 | 5 | 5 |
Q1 2023 | 2 | 0 | 9 | 7 | -1 |
Hedge funds changes in Cyclerion Therapeutics stock options (Q1 2019 – Q1 2023)
Q1 2019 | 90,000 | 0 |
---|---|---|
Q2 2019 | 0 | 0 |
Q3 2019 | 0 | 0 |
Q4 2019 | 0 | 0 |
Q1 2020 | 0 | 0 |
Q2 2020 | 0 | 2,000 |
Q3 2020 | 76,000 | 0 |
Q4 2020 | 21,000 | 57,000 |
Q1 2021 | 59,000 | 100,000 |
Q2 2021 | 2,074,000 | 779,000 |
Q3 2021 | 1,590,000 | 456,000 |
Q4 2021 | 705,000 | 108,000 |
Q1 2022 | 400,000 | 2,000 |
Q2 2022 | 254,000 | 0 |
Q3 2022 | 401,000 | 0 |
Q4 2022 | 307,286 | 1,575 |
Q1 2023 | 8,158,000 | 0 |